Introduction
Specialized signaling pathways drive the differentiation of human embryonic stem cells (hESCs) toward specific cell fates, but how these signaling networks cooperate with chromatin state has not been extensively investigated. hESCs have highly euchromatic chromatin and, upon differentiation, heterochromatic regions begin accumulating (Meshorer and Misteli, 2006) . Within this euchromatic signature, hESCs have a prevalent histone signature, called a bivalent domain, where promoters are associated with both active (H3K4me3) and repressive (H3K27me3) histone marks (Bernstein et al., 2006; Ku et al., 2008) . A particular bivalent conformation, with broad marks of both H3K4me3 and H3K27me3 across promoters, exhibits a significant association with the promoters of developmentally regulated genes. This bivalent domain in hESCs has been hypothesized to 'poise' developmental genes for rapid activation (Bernstein et al., 2006) . Indeed, several reports have shown that bivalent domains are resolved into either repressive (H3K27me3) or active (H3K4me3) states upon differentiation, suggesting that cell fate commitment may require the release of this primed bivalent state (Bernstein et al., 2006; Mikkelsen et al., 2007; Pan et al., 2007; Zhao et al., 2007) . While hESCs harbor a significant number of bivalent domains at developmental promoters, this chromatin conformation exists to a lesser degree in more differentiated cell types as well, including mouse embryonic fibroblasts (MEFs), neural progenitor cells (NPCs) and T cells, suggesting that these domains continue to mark promoters for further functional and rapid activation (Bernstein et al., 2006; Cui et al., 2009; Mikkelsen et al., 2007; Pan et al., 2007; Zhao et al., 2007) . While the bivalent domain is hypothesized to allow rapid activation of molecules critical to guiding specific differentiation events, there is very little molecular or biological evidence that supports this general hypothesis, other than the important biochemical observation describing this interesting domain. Signaling molecules must play a role -either actively or passively -in the depletion of the repressive mark, H3K27me3, and the accumulation of the active mark, H3K4me3, at these specific developmentally important regions. It is imperative that the interplay between these marks and specific transcription Developmental Biology 357 (2011) 492-504 factors are monitored through this process, together, during the differentiation from pluripotency to a more differentiated state.
Endoderm is one of the first cell types to emerge during embryogenesis and does so under the control of the Nodal signaling pathway. hESCs can be driven toward endodermal fates by activation of the Nodal signaling pathway, which utilizes serine threonine kinase receptors to phosphorylate the intracellular proteins SMAD2 and SMAD3 (Attisano and Wrana, 2000; Schier, 2003; Shen, 2007) . These proteins translocate into the nucleus and form an association with FOXH1 at regions within the genome. Several direct targets of SMAD2/3/4 and FOXH1 have been elucidated, including GSC, PITX2, LEFTY1, LEFTY2, NODAL and CADHERIN (Izzi et al., 2007; Saijoh et al., 2003; Shiratori et al., 2001; Takaoka et al., 2006; von Both et al., 2004) . Genome-wide analysis of EOMES suggests that it is a key regulator of SMAD2/3 at overlapping promoters leading to the initial phases of endoderm formation (Teo et al., 2011) . However, little is known regarding how the SMAD2/3/4 and FOXH1 complex assembles at specific genomic regions in a cell type specific manner. Much less is known about how this complex interacts with chromatin to release a repressive state. Recently, a mechanism has been proposed: Dahle et al. (2010) demonstrated that SMAD2/3 was capable of recruiting the histone demethylase, JMJD3, to the NODAL promoter in mouse ESCs, causing the loss of the repressive mark H3K27me3. This strongly suggests that a SMAD2/3/JMJD3 complex acts directly on the repressive chromatin state, leading to transcriptional activation.
Nodal signaling is also required for self-renewal in hESCs (Besser, 2004; James et al., 2005; Vallier et al., 2005 Vallier et al., , 2009 Xu et al., 2008) which appears contradictory as it is also involved in the first stages of endoderm commitment (D'Amour et al., 2005 (D'Amour et al., , 2006 . As Nodal has strong dose-dependent effects on cell fate specification, it is likely that the decision between maintaining pluripotency versus differentiation is due to significant changes in downstream effects in response to varying levels of Nodal signaling. The effect of Nodal in self-renewal may also be dependent upon the distinct chromatin state existing in hESCs, including open chromatin and large array of bivalent domains (Bernstein et al., 2006; Ku et al., 2008; Meshorer and Misteli, 2006) .
To examine how Nodal signaling interacts and effects particular chromatin states during hESC self renewal and endoderm commitment, we used ChIP-seq to generate genome-wide target maps for Nodal downstream transcription factors, including SMAD2/3, SMAD3, SMAD4, FOXH1 and the chromatin marks, H3K4me3 and H3K27me3, in hESCs and derived endoderm (D'Amour et al., 2005 (D'Amour et al., , 2006 . Interestingly, we find that endoderm derived from hESCs has a wider array of bivalent domain structures than hESCs. At promoters of genes critical for differentiation, we observe a significant depletion of H3K27me3 only with a specific bivalent context. These 'resolving' bivalent domains are highly correlated with SMAD2/3 binding. We further show that the resolution of these regions occurs together with SMAD2/3 accumulation within the first 24 h of differentiation and are associated with JMJD3. This suggests that the resolution of the bivalent domain is not a cause or effect of SMAD2/3 binding, but a cooperative association between the transcription factor and chromatin context.
Material and methods

ChIP
ChIP was performed as previously described (Johnson et al., 2007) . 5×10 6 cells were used for each ChIP. Cells were cross-linked with 1%
formaldehyde for 15 min at room temperature and the cross-linking was stopped by adding Glycine (to be 125 mM) for 5 min. The crosslinked cells were lysed in 500 μl of lysis buffer (50 mM Tris pH8.1, 10 mM EDTA, 1% SDS) with protease inhibitor cocktail (Roche). After being diluted in 1.5 ml of IP buffer (25 mM Tris pH 8.0, 150 mM NaCl, 0.01% SDS, 0.5% Deoxycholate, 1% TritonX-100, 5 mM EDTA), the cell lysate was sonicated to generate 200-to 600-bp fragments. Fragmented chromatin was immunoprecipitated with magnetic beads coupled with 5 μg of each antibody. The antibodies used were anti-SMAD2/3 (A; Santa Cruz, sc-8332, B; R&D Systems, AF3797), anti-SMAD3 (Abcam, ab28379), anti-SMAD4 (R&D Systems, AF2097), anti-FOXH1 (R&D Systems, AF4248), anti-JMJD3 (Abgent, AP1022a), anti-H3K4me3 (Abcam, ab8580) and anti-H3K27me3 antibody (Upstate, 07-449). The pulldowned beads with immune complexes were washed twice each with low salt buffer (50 mM Tris pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% Deoxycholate, 1% NP40, 1 mM EDTA), high salt buffer (50 mM Tris pH 8.0, 500 mM NaCl, 0.1% SDS, 0.5% Deoxycholate, 1% NP40, 1 mM EDTA), LiCl wash buffer (50 mM Tris pH 8.0, 250 mM LiCl, 0.5% Deoxycholate, 1% NP40, 1 mM EDTA) and Tris-EDTA buffer (10 mM Tris pH 8.0, 1 mM EDTA) for 10 min at 4°C. Immune complexes were eluted in elution buffer (1% SDS, 0.1 M NaHCO 3 ) for 1 h at 65°C and reverse cross-linked for 6 h at 65°C. For sequential ChIP, the immune complexes from the first pulldown were eluted in the elution buffer for 1.5 h at 37°C. After diluted in IP buffer, the complexes were immunoprecipitated with beads coupled with second antibody, and washed and eluted again in the elution buffer for 1 h at 65°C. Reverse cross-linked DNA was purified by phenol/chloroform extraction and further by QIAquick PCR purification kit (Qiagen) and an aliquot was used for PCR validation. We performed these ChIPs at least six times for each of the antibodies and the qPCR levels had to be above 10× enriched above input control in each of the six replicates in order to move forward with making a sequencing library.
Sequencing and data processing
Sequencing libraries were prepared using Genomic DNA Sample Kit (Illumina) according to the manufacturer's protocol. The ChIP-seq libraries were sequenced by Genome Analyzer II (Illumina). Reads were 36 bp, and we used Eland to map the first 25 bp to human genome assembly hg18 and mismatches up to 3 bp were allowed. Only uniquely mapping reads were kept. Shifts were calculated within the peak calling programs QuEST 2.4 (Valouev et al., 2008) and CisGenome (Ji et al., 2008) . The negative control for sequencing was the Input control library.
Transcription factor ChIP-seq reads were processed to call peaks using CisGenome. The setting for peak-calling and sliding window size was 300 bp and the threshold number of reads required for peak to be called was 11 reads. The false discovery rate allowed was 0.01. The resulting peaks were mapped to the human genome hg18 to identify the locations and numbers of peaks around annotated genes. Histone H3K4me3 and H3K27me3 peaks were called using QuEST 2.4. We used the "histone" bandwidth setting with "relaxed" peak-calling parameters.
Transcription factor binding regions and associated genes
We parsed the peaks to determine distributions across the gene body. UCSC Known Genes (Human browser hg18) were used to locate the peaks into annotated genomic regions, exon, intron, promoter (±10 kb from transcription start site (TSS)) or intergenic region. We then associated genes for each peak and the nearest genes within 1 Mb, 100 kb, 10 kb and 1 kb from TSS were counted. If additional genes were within 25% of the distance to the closest genes, they were also associated with the binding site. Further, we examined the numbers of genes lying within the binding sites between hESCs and endoderm within the same distance categories.
Xenopus tropicalis ortholog identification and in situ hybridization X. tropicalis orthologs of candidate human Nodal signaling target genes were identified by overall sequence homology validated by synteny between the human and X. tropicalis sequences (identified using Metazome). ESTs for the corresponding X. tropicalis gene were identified using the JGI genome browser, and IMAGE clones containing appropriate ESTs were used as probes for in situ hybridization. Linearized plasmid was reverse-transcribed and labeled with DIG-UTP according to standard methods, and in situ hybridization using a multibasket technique was carried out as described in Khokha et al. (2002) .
Histone peak clustering
We used K-means clustering (http://bonsai.ims.u-tokyo.ac.jp/ mdehoon/software/cluster/software.htm) to visualize the H3K4me3 and H3K27me3 surrounding TSS in the genome. The wiggle/enrichment plots represent normalized enrichment over the background. The data points were the normalized enrichment values that are calculated by QuEST. The log2(enrichment) values were used for clustering and plotting. H3K4me3 and H3K27me3 marks were analyzed depending on their patterns within ±5 kb of the TSS from UCSC Known Genes. For gene loci with isoforms with alternate TSS's, we chose the TSS with the largest H3K4me3 peak. Genes with a TSS within 10 kb of another gene TSS were discarded for clustering analysis.
To functionally define these clusters, GO analysis was performed using PANTHER (Protein Analysis through Evolutionary Relationships) (www.pantherdb.org). In addition, we examined how Groups 1-9 are correlated with transcriptional activation in the context of endoderm. To this end we used microarray timecourse of hESC differentiation into endoderm to associate the behavior of transcripts, whether induced, constitutive, inactive or repressed with a specific histone grouping (1-9). We compared the transcriptional levels of day 5 derived endoderm (d5) with hESCs (d0). For each gene, we calculated the fold change (R), difference (D) between the means of the two groups, and the Welch's t-test p-value using dChip (Li and Wong, 2001) . Induced genes were defined by R N 2 and D N 100 of d5 over d0, and P ≤ 0.05. Repressed genes were defined by R N 2 and D N 100 of d0 over d5, and P value ≤ 0.05. We also calculated the logarithm-transformed average (A) and difference (M) of the means of d0 and d5 for each gene. We calculated the z-scores of A (Z A ) and the z-scores of M (Z M ) for all genes. Constitutive genes were defined by Z A N 1 and Z M b 1. Inactive genes were defined by Z A b −1 and Z M b 1.
Results
Timecourse microarrays and extensive protein validation support endoderm formation from hESCs
To characterize the downstream Nodal targets during the differentiation of hESCs into the endodermal lineage and to determine how this important signaling pathway interacts with chromatin, we first extensively validated our derivation of endodermal cells from hESCs. To this end, endodermal cells were derived from hESCs after a 5-day treatment with Activin ( Fig. 1A) , which acts as a Nodal analog (McLean et al., 2007; Schier, 2003; Shen, 2007) . The efficiency of endoderm differentiation was rigorously examined using multiple methodologies, including determining the transcriptome of cells through time, analyzing the expression of endoderm specific proteins -with and without Nodal chemical inhibitors -and validating each timecourse using qPCR. To this end, we performed an extensive microarray timecourse during hESC differentiation into endoderm post Activin treatment, examining at days 0, 1, 3 and 5. The timecourse microarray data were deposited to the publicly available repository of GEO (accession number GSE29421). Several critical lineage specification genes including GSC, MIXL1 and EOMES are highly enriched (more than 40 fold) after the first 24 h of differentiation (Fig. 1B) . Mesodermal markers are also expressed after 24 h of differentiation, including BRA and FGF4 suggesting the presence of a mesendodermal intermediate (Fig. 1B) (D'Amour et al., 2005; Liu et al., 2007) . The transcripts of endoderm markers SOX17, FOXA2 and CXCR4 are upregulated (6-22 fold) as early as day 3 of differentiation while markers for other germ layers, including mesoderm, are no longer expressed. Also, starting at day 3 of differentiation the protein levels of endoderm markers GATA4, GATA6, SOX17 and FOXA2 are induced (Fig. 1C) .
While extensive transcript profiles have been examined during endoderm commitment after exposure of hESCs to Activin, the dynamics of protein expression and sensitivity to Activin signals have not been demonstrated (D'Amour et al., 2005; Liu et al., 2007) . Using western analysis to examine protein expression and its dependency on Nodal signaling, we examined multiple endodermal markers as well as the SMAD2/3 and FOXH1 proteins themselves throughout the course of endoderm differentiation at days 0, 1, 3, 4 and 5 post Activin treatment in the presence or absence of the Nodal chemical inhibitor, SB431542. This SB431542 inhibitor is known to be specific for SMAD2/3 signaling by inhibiting type I TGF-β receptors and has been studied in hESCs (Vallier et al., 2009; Xu et al., 2008) . Here we show that the expression of phosphorylated SMAD2 (pSMAD2) and FOXH1 is upregulated in the nucleus as early as day 1 of differentiation after exposure to Activin. These proteins are clearly co-localized within the nucleus of the derived endodermal cells (Fig. 1D , E and F). Furthermore, pSMAD2 and FOXH1 expression is highly dependent on Nodal signaling as both proteins diminish following SB431542 treatment (Fig. 1E) . Additionally, the endoderm markers LEFTY, GATA4, GATA6 and SOX17 were highly induced during differentiation as early as day 3 and maintained high level of expression throughout the rest of the timecourse (Fig. 1G ). OCT4, a pluripotency marker, was strongly expressed in the nucleus of hESCs but decreased sharply during endoderm differentiation ( Fig. 1C and E). This pattern is not the same for the OCT4 transcript, which remains abundant during the first few weeks of hESC differentiation in our timecourse microarray data, suggesting that the expression of OCT4 is more tightly controlled posttranscriptionally. When SB431542 was added during the third day of differentiation in Activin, LEFTY and GATA6 expression rapidly decreased within 24 h. Conversely, GATA4 and SOX17 showed weak or little reduction in protein in response to Nodal signaling inhibition when occurring on the third day of endoderm differentiation suggesting they are less dependent upon Nodal signaling or that these proteins are more stable. Interestingly, we have also shown that protein expressions of LEFTY, GATA4, GATA6 and SOX17 were completely inhibited if we treated cells with SB431542 at the beginning of differentiation of hESCs rather than day 3 differentiated cells, confirming that the initial expression of GATA4, GATA6, SOX17 and LEFTY are all dependent on Activin treatment (Yoon et al., unpublished results) . Taken together, these results validate that, as in earlier studies, Activin/Nodal signaling drives definitive endoderm formation in hESCs and demonstrate fundamental expression differences in response to Nodal signaling.
Genome-wide target analysis of SMAD2/3/4, FOXH1, H3K4me3 and H3K27me3 in hESCs and derived endoderm
To examine the dynamics of the Nodal signaling pathway and associated chromatin marks during differentiation of hESCs into endoderm, we performed genome-wide location analysis using ChIPseq for SMAD2/3, SMAD3, SMAD4, FOXH1, H3K4me3 and H3K27me3. To this end, we examined multiple antibodies against SMAD2/3, SMAD3, SMAD4 and FOXH1 for their ability to pull down chromatin in both hESCs and derived-endoderm and found several, including two SMAD2/3 antibodies (anti-rabbit; SMAD2/3_A and anti-goat; SMAD2/3_B, Table 1) neither of which were phospho-specific, but which were highly effective for ChIP based upon extensive validation shown in Fig. S1 . By using ChIPqPCR, we analyzed the enrichment of several known SMAD targets, including LEFTY1 and LEFTY2 (Fig. S1A ) in all SMAD2/3, SMAD3, SMAD4 and FOXH1 ChIP samples. GAPDH intronic sequences were used as negative control. After validation, three biological replicate ChIPs were pooled from each antibody, as well as input controls, for both hESCs and derived endoderm. Libraries were then generated and sequenced with an Illumina Genome Analyzer II. The resulting sequence tags were mapped to the human genome (hg18) using Eland and binding sites were identified using CisGenome (Ji et al., 2008) . The ChIP-seq data are available in GEO (accession number GSE29422). For SMAD2/3_A, SMAD2/3_B, SMAD3, SMAD4 and FOXH1, we generated 10.2, 8.7, 6.9, 9 and 10.4 million mapped reads in hESCs and 9.6, 5.9, 6.1, 6.1 and 10.8 million mapped reads in derived endoderm, respectively (Table 1) . Since there were thousands of SMAD bound regions in both hESCs and endoderm, we validated these datasets using two methods. First, we compared bound regions elucidated from the two SMAD2/3 antibodies (A and B) and found a high degree of overlap in both hESCs and derived endoderm (93% and 78%, respectively), showing that two independent antibodies pulled down highly overlapping regions. As the overlap was extensive, and the B dataset was far more comprehensive, all subsequent analysis was performed using the B dataset. The degree of overlap generated from two independent antibodies highly validates the dataset. Examples of bound regions are illustrated in Fig. 2 . For further validation, we performed ChIP-qPCR at predicted loci with or without SMAD signaling present. To this end, we treated hESCs with SB431542 during the first 24 h of differentiation. We then examined by ChIP-qPCR whether SMAD2/3 and FOXH1 were still associated with the predicted binding regions in the absence of Nodal signaling. We found that every examined region was affected by SB431542 treatment, strongly indicating that they are regions bound directly by SMAD2/3 and FOXH1 and are downstream targets of Nodal/Activin signaling (Fig. S1B) . For H3K4me3 and H3K27me3, we generated 7.3 and 17.9 million mapped reads in hESCs and 10.3 and 19.6 million mapped reads in derived endoderm, respectively (Table 1) . Since H3K4me3 and H3K27me3 marks have far wider distribution than the binding of transcription factors, we sought to address whether our depth of sequencing reached saturation. To this end, we called peaks from pooled reads (two biological replicates for H3K4me3 and three for H3K27me3) and checked the levels of saturation of unique peaks called. H3K4me3 reads reached saturation, but not H3K27me3 even after additional sequencing (Fig. S2) . These data suggest that either more extensive sequence depth might be necessary or that H3K27me3 marks are more variable than H3K4me3 marks, consistent with initial data generated in hESCs and analysis performed by Sharov and Ko (2007) (Pan et al., 2007; Zhao et al., 2007 ; available in GEO: GSE29422).
SMAD2/3/4 associate with different regions in hESCs and derived endoderm
To determine how dynamic SMAD and FOXH1 binding is between hESCs and derived endoderm, we examined the genomic distribution of identified Nodal signaling peaks. We first designed a Python script to search through UCSC Known Genes (Human browser hg18) to locate the peaks into annotated exon, intron, promoter or intergenic regions (Fig. 3A) . We found that in hESCs, SMAD2, SMAD3 and SMAD4 are bound at similar frequencies to each of these genomic regions with 50-60 % of binding occurring in exons and promoters. In contrast, in derived endoderm, only 10-15 % of SMAD binding occurs in exons and promoters. Surprisingly, the genomic distribution of FOXH1 peaks remains more constant between these two cell types, exhibiting a high degree of binding (80-85%) outside exons and promoters. This mimics the distribution of SMADs within derived endoderm, but not in hESCs. These observations suggest that SMAD transcription factors are highly dynamic in regard to their genomic distribution even within the 5 days that separate hESCs from endoderm. As SMAD binding is dynamic between hESCs and derived endoderm, we sought to define how these peaks are utilized in the different cells. By analyzing the common sites for each transcription factor in both hESCs and derived endoderm, we found that most of the SMAD peaks change upon differentiation. Only 3% (459/14,833) of SMAD2/3 peaks in hESCs are retained in the derived endodermal cells (Fig. 3B) . A similar pattern is observed for SMAD3 (6.7%; 180/2688) and SMAD4 (8.8%; 345/3936). On the other hand, FOXH1 retains almost 50% (4346/9702) of its hESCs peaks upon differentiation toward endoderm, while the large number of additional sites is observed in derived endoderm. Together, this suggests that a vast change in transcription factor occupancy is triggered upon differentiation toward endoderm.
SMAD2/3/4 associate with similar genes in hESCs and derived endoderm Although SMAD2/3 binding is highly dynamic at bound regions during differentiation into endoderm, we asked whether these regions are associated with similar genes. To this end, we associated bound regions for all transcription factors with the nearest gene TSS (UCSC Known Gene) within 1000 kb (1 Mb), 100 kb, 10 kb and 1 kb (Table 1 ). To validate whether these genes might be involved in SMAD signaling, we stringently selected a high value group of 322 target genes by examining regions bound by all SMAD2/3, SMAD3 and SMAD4 in both of hESCs and endoderm (see Supplemental excel file). To obtain spatial information in the embryo, we then cloned the X. tropicalis orthologs of 42 of these target genes and performed in situ hybridization during gastrulation stages. We found that 45% (19/42) of these had specific endoderm or mesoderm expression patterns during gastrulation. This is an extremely high hit rate, especially considering that 29% (12/42) of the probes did not provide a signal, which could simply be due to probe design. Some of these expression patterns are represented in Fig. 3D , while the rest are in Supplemental Figure S3 . Overall this suggests that the SMAD target datasets do indeed identify neighboring genes that are expressed embryonically at the temporal and spatially appropriate times for being involved in Nodal signaling.
To determine the overlap between genes neighboring SMAD bound regions, we compared target genes between hESCs and derived endoderm. We found that the genes associated near SMAD bound regions remained more consistent between hESCs and derived endoderm compared to the regions themselves. For example, 60% . Genes bound by transcription factors within 10 kb were analyzed. "None" (in C and D) are genes that do not have any binding regions of SMAD2/3, SMAD3, SMAD4 and FOXH1 at the given distance. Box plots show 25th, 50th, and 75th percentiles of log2 expression levels for genes in each group. Whiskers represent 5 and 95 percentile of genes in each group. Student t-tests were performed on each group comparing with appropriate 'None' group. One asterisk denotes P b 0.05 and two asterisks P b 0.01. The presence of a SMAD2/3, SMAD3, SMAD4 or FOXH1 binding event within 1 kb from TSS is significantly correlated with an increase in transcriptional levels, above background levels (In hESCs, P = 1.5E-50, 5.6E-38, 2.5E-15 and 5.6E-16, respectively; In endoderm, P = 3.5E-12, 8.7E-12, 1.7E-05 and 4.3E-12, respectively). Further, the presence of three or more binding regions of SMAD2/3, SMAD3, SMAD4 or FOXH1 is highly correlated with increased transcription levels in endoderm, above background levels (In hESCs, P = 2E-10, 9.2E-08, 6E-05 and 7.8E-04, respectively; In endoderm, P = 1.5E-22, 9.5E-16, 1.7E-09 and 7.9E-07, respectively).
(1134/1905) of the genes neighboring SMAD2/3 sites in derived endoderm were also associated in hESCs, compared to 16% (459/2915) when comparing genomic binding sites alone ( Fig. 3B and Supplemental file). Thus while individual SMAD proteins associate with DNA in a dynamic fashion during differentiation, they tend to occupy regions surrounding similar genes, suggesting that different loci within gene regulatory domains are used to mediate distinct cellular transcriptional responses. SMAD2, SMAD3, SMAD4 and FOXH1 are known to regulate similar downstream targets in a variety of cellular contexts and are known to form complexes at these sites (Attisano et al., 2001; Silvestri et al., 2008) . Therefore, we examined the overlapping targets between these transcription factors. We found that, in both hESCs and derived endoderm, all SMAD transcription factors are bound near a highly overlapping set of genes, regardless of the distance examined from TSS (Fig. 3C, S4 and Supplemental file) with most bound by all three proteins (1004 within 100 kb). Comparison between the putative target genes for the SMAD2, SMAD3 and SMAD4 with those of FOXH1 shows that while some overlap exists in hESCs (Fig. S5) , due to the overwhelming genome-wide occupancy of FOXH1, it is extensive in derived endoderm, encompassing almost all (99%; 1879/1905) of SMAD2/3 and (98%; 2694/2753) of SMAD4 target genes within 100 kb (Fig. 3C) . necessarily affect transcriptional activity, we sought to understand how these binding signatures correlate with gene expression output. By using the timecourse microarray (days 0, 1, 3 and 5) and the ChIP-seq target datasets, we can identify the bound sites correlated with increased transcription. Several critical lineage specification genes including GSC, MIXL1 and EOMES are highly enriched (more than 40 fold) after the first 24 h of differentiation (Fig. 1B) . SMAD proteins are bound to regions surrounding each of these developmentally important genes in both hESCs and derived endoderm. In each cellular context the nature of SMAD2/3/4 binding changes (Fig. 2) . For example, upon differentiation to endoderm, EOMES and GSC are bound by SMAD2/3/4 in regions not bound in hESCs (Fig. 2 dotted black boxes) . Conversely, several regions bound in hESCs are lost in endoderm.
To elucidate the most predictive signature of SMAD2/3/4 or FOXH1 binding that can be correlated with transcriptional activation, we examined all regions in the genome within 1 kb, 10 kb and 1 Mb from a TSS, and identified those bound by SMAD2/3/4 or FOXH1 in both hESCs and derived endoderm. We next correlated these binding events with neighboring gene transcription levels, which were compared with transcriptional levels of genes with no detectable binding. Interestingly, we find that in both hESCs and derived endoderm, the presence of a SMAD2/3, SMAD3, SMAD4 or FOXH1 binding event within 1 kb of a TSS is significantly correlated with an increase in transcriptional levels, above background levels (Student's t-test; In hESCs, P = 1.5E-50, 5.6E-38, 2.5E-15 and 5.6E-16, respectively; In endoderm, P = 3.5E-12, 8.7E-12, 1.7E-05 and 4.3E-12, respectively; Fig. 4A and B) . Once this distance is expanded to 10 kb or 1 Mb, this correlation becomes less significant for all transcription factors.
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Peak Level (log2 R) events were more predictive of transcriptional activity than isolated binding events. In derived endoderm, we find that multiple binding events within the extended promoter region are highly correlated with increased transcription levels. Further, the more bound regions within this interval, the more significant the correlation. This correlation is particularly strong for regions containing three or more SMAD2/3 or SMAD3 bound sites in derived endoderm (Student's t-test; P = 1.5E-22 and 9.5E-16, respectively; Fig. 4C and D) . In hESCs, all SMAD association within 10 kb is highly predictive of transcriptional increase. Overall, this data strongly suggests that in endodermal cells, Nodal signaling targets are more likely to be transcriptionally activated if surrounded by concentrated regions of binding within 10 kb of the TSS.
Endoderm differentiation involves establishment of new bivalent domains
As it is known that occupancy of H3K4me3 and H3K27me3 changes during differentiation, particularly at bivalent regions, we sought to examine how these marks change during endoderm commitment. To this end, we used K-means clustering to visualize ChIP was performed with anti H3K27me3 (K27) and H3K4me3 (K4) antibodies in hESCs and CXCR4 positive endodermal cells. Fold enrichment for each ChIP was calculated compared to the value of SERPINA1, a negative control for H3K4me3 and H3K27me3. The EOMES_TSS primer set was used for qPCR. K27_K4; 1st ChIP with K27 and 2nd ChIP with K4, K27_K27; both 1st and 2nd ChIP with K27, K27_IgG; 1st ChIP with K27 and 2nd ChIP with rabbit total IgGs, K27(10%); 10% of 1st K27 ChIP. (C) ChIP-qPCR for SMAD2/3, FOXH1 and H3K27me3 (K27) in the promoter regions of GSC and EOMES during hESC differentiation at 6, 12 and 24 h after Activin treatment. GAPDH is a negative control for SMAD2/3 and FOXH1 binding. (D) ChIP-qPCR for JMJD3 in the promoter regions of GSC and EOMES during hESC differentiation at 6, 12 and 24 h after Activin treatment. GAPDH is a negative control for JMJD3 binding.
H3K4me3 and H3K27me3 enrichment in a 10 kb centered window around 16,621 TSSs in both hESCs and derived endoderm (Heintzman et al., 2007; Hon et al., 2008) . This analysis led to a clear demarcation of nine different groups (1-9) containing unique signatures that exist in both cell types ( Fig. 5A and Supplemental file). Gene ontology (GO) analysis revealed highly significant and unique biological functions for different groups (Table S1 and Supplemental file), particularly the bivalent group with the strongest and widest H3K27me3 marks, which is highly significant for genes with roles in developmental processes (Group 1; Developmental group; P = 1.1E-88) (Bernstein et al., 2006; Ku et al., 2008) . Indeed Group 1 contains the key regulators of endoderm formation, including EOMES, GSC, PITX2, SOX17, GATA4 and GATA6.
While it is known that the bivalent motif exists in various forms (Cui et al., 2009; Ku et al., 2008; Mikkelsen et al., 2007; Pan et al., 2007) , we were surprised to see how many different patterns emerged upon clustering. Interestingly, differentiation into endoderm appears to not only maintain many bivalent domains from hESCs, but also establishes new bivalent domains as well. To test whether these groups reflected true bivalent domains where both marks were present on the same nucleosome and not the result of heterogenous endoderm populations, we performed sequential ChIP-qPCR for H3K4me3 and H3K27me3 at specific promoters in both hESCs and derived endoderm. We examined the promoters of MYOD and ASCL1 (which belong to Group 1), KCND2 (Group 5), LECT1 and CLDN10 (Group 6), and GAPDH (Group 3). These promoters were selected from each group to represent the different bivalent domains depicted in Fig. 5A . In both hESCs and derived endoderm, we performed ChIP first with anti-H3K27me3 and then reprecipitated with antiH3K4me3. Total rabbit IgGs were a negative control for the second pulldown. We find that in each case the sequential ChIP results support the finding that both marks are present within a single nucleosome or, at least, the histone marks are on adjacent nucleosomes (as we sonicated DNA to generate 200-to 600-bp fragments). For example, the clustering of Group 1 promoters demonstrates broad H3K4me3 and H3K27me3 in both hESCs and derived endoderm (Fig. 5A ). Sequential ChIP shows that, at the Group 1 genes, MYOD and ASCL1, the bivalent mark is present in the same or neighboring nucleosomes in both cell types (Fig. 5B) . Whereas in Groups 5 and 6 promoters, which become bivalent only in derived endoderm, sequential ChIP at KCND2 (Group 5), LECT1 (Group 6) and CLDN10 (Group 6) promoters show both marks present together only in derived endoderm (Fig. 5B) . Overall, sequential ChIP supports the hypothesis that bivalent domains are both maintained and enhanced in derived endoderm.
Endoderm-specific transcription in Group 1 is associated with H3K27me3 depletion and SMAD2/3 accumulation While bivalent regions are prevalent in endoderm, we asked whether these domains were altered at actively transcribed genes. To this end, we correlated each promoter group (1-9) with induction of transcription during differentiation into endoderm. Histogram plots of the amount of H3K4me3 and H3K27me3 at each induced region for each group are shown in Fig. 6A . While the bivalent conformation is still observed, H3K27me3 levels are depleted and H3K4me3 increased only at promoters in Group 1 and in Group 4 in this endodermally expressed subset (Groups 1 and 4; all P for H3K4me3 and H3K27me3 were b1.0E-06, see Material and methods for statistical analysis). Overall this suggests that the promoters of Group 1 genes that are associated with transcriptional activation, exhibit relative depletion of H3K27me3 and accumulation of H3K4me3.
We next determined whether SMAD2/3 binding could be associated with the chromatin changes observed at these few loci in the Group 1 bivalent domains. To this end, we examined whether SMAD2/3 binding within 100 kb of the TSS could be associated with the H3K27me3 depleted regions. Of the 32 Group 1 promoter regions associated with endodermal transcriptional activation, 21 genes were bound within 100 kb by SMAD2/3. All 21 of these regions displayed almost complete depletion of H3K27me3 in endoderm compared to the other bivalent genes in Group 1 (Figs. 2 and 6B) (both P for H3K4me3 and H3K27me3 were b1.0E-06). Interestingly, the 21 bound regions included EOMES, GSC, SOX17, GATA4, GATA6 and FOXA2, all known to play important roles in endoderm commitment ( Fig. 2 and Table S2 ). The remaining 11 regions of Group 1, which are associated with transcriptional activation and chromatin alterations, are not bound by SMAD2/3 within 100 kb. However, they are bound by SMAD4 or by SMAD2/3 using other criteria: this includes four genes, NOG, HNF1B, AHNAK and MSX2, which are bound by SMAD4 within 100 kb, and four genes, NOG, PCDH7, CYP26A1 and MSX2, which are bound by SMAD2/3 within 1 Mb. We further validated this result by examining biochemically H3K4me3 and H3K27me3 marks in hESCs and derived endoderm at two of the 21 'resolving promoters' (Fig. 7A) . We performed ChIP-qPCR using primers that tiled the GSC and EOMES promoters for H3K4me3 and H3K27me3 (Fig. 2) . Importantly, in agreement with our findings from genomic analysis, H3K27me3 is depleted or significantly reduced across the promoters only after endoderm differentiation. In addition, we examined whether the H3K27me3 depletion occurs in the same nucleosome during differentiation. To this end, we performed sequential ChIP-qPCR for H3K4me3 and H3K27me3 in hESCs and endoderm at the EOMES promoter. Both marks are precipitated together in the hESC nucleosomes of the EOMES promoter, but not in derived endoderm, further indicating that at these loci and within the same nucleosome the bivalent domain has been resolved (Fig. 7B) . Taken together, this suggests that SMAD2/3 or a family member plays an important role in bivalent resolution within these regions which are critical for endodermal specification and provides a system in which to study how these key 'poised' regions become activated.
SMAD2/3, FOXH1, JMJD3 and H3K27me3 association dynamics during the first 24 h of differentiation As H3K27me3 depletion occurs at active Group 1 bivalent promoters associated with SMAD2/3, we next investigated the kinetics of this depletion over the course of 24 h. Since it was shown recently that SMAD2/3 can recruit the histone demethylase, JMJD3, to the NODAL promoter where it actively demethylates H3K27me3 (Dahle et al., 2010) , we further propose that this might be a common mechanism occurring within the 32 Group 1 resolving promoters. Therefore, we performed timecourse ChIP-qPCR using SMAD2/3, FOXH1, H3K27me3 and JMJD3 during hESC differentiation into endoderm at 6, 12, and 24 h at two sites near GSC and EOMES. Surprisingly, we find that most of the SMAD2/3, FOXH1 and JMJD3 accumulation and H3K27me3 depletion occur simultaneously, even as early as 6 h post Activin treatment ( Fig. 7C  and D) . Interestingly, while SMAD2/3 and FOXH1 binding at these regions continues to increase throughout the 24 h window, JMJD3 appears to peak at 6 h, diminishing by 24 h. This is consistent with JMJD3 role as a demethylase as by 24 h there is far less association of H3K27me3 to these regions, suggesting that the methylation is lost rapidly within the first day of differentiation and that JMJD3 plays a key role, not only at the NODAL locus, but also at many others as well. These protein dynamics are highly consistent with the transcriptional activation of GSC and EOMES, which are rapidly transcribed in the first 24 h after Activin treatment, at levels 40-50 fold higher than found in hESCs.
Discussion
A single broad class of bivalent domains known to be highly enriched at promoters for important developmental factors has been proposed to be 'poised' for rapid differentiation. Here we provide genomic and biochemical evidence that substantiate this observation, at least during endoderm commitment from hESCs. We find that within the developmental class of bivalent promoters (Group1), SMAD2/3, FOXH1 and JMJD3 accumulate simultaneously with the depletion of H3K27me3 within the first 24 h of differentiation. This occurs at critical promoters for endoderm commitment, including GSC and EOMES, correlating with their transcriptional activation within the 24 h of Activin treatment. Furthermore, this implies that resolution of bivalent domains upon differentiation at critical promoters involves interplay between transcription factors and associated chromatin marks. In the case of endoderm, this association appears to be occurring at very few regions. This study presents thousands of regions bound by the SMAD complex and then narrows these regions down to a critical 32 that appear to be central to endoderm commitment. In the future it will be very interesting to understand mechanistically how these 32 regions are singled out for JMJD3 association and subsequent bivalent resolution.
Intriguingly, we observed an increase in bivalent domains as hESCs differentiate into endoderm. This maintenance and expansion of bivalent promoters is distinct from many other cell types. While bivalent domains are prevalent in hESCs, encompassing more than 2000 promoters in the genome, most of these bivalent domains become monovalent in more differentiated cell types (Bernstein et al., 2006; Cui et al., 2009; Mikkelsen et al., 2007; Pan et al., 2007; Zhao et al., 2007) . While a small fraction (less than 20%) of monovalent genes have been shown to become bivalent in more differentiated cell types including MEFs and NPCs (Mikkelsen et al., 2007; Zhao et al., 2007) , we showed that most of the monovalent genes marked by H3K4me3 appear to become bivalent during endoderm formation (as observed in Groups 3, 5, 6 and 7). We suggest that this increase in bivalent promoters in endodermal cells is due to the fact that endoderm is one of the first cell types that arise in the embryo and therefore must maintain a degree of plasticity. It may therefore be expected that multipotent cell types in general retain a bivalent conformation at many promoters and may even utilize new subtleties in this conformation to activate gene transcription.
As cells differentiate into endoderm, SMAD transcription factors bind to discrete target sequences. Some of these binding events lead to gene transcription, while others remain 'inert'. Though the mechanics that govern the selection between these activities is unknown, it is becoming clear that chromatin plays a key role. Recently, a number of studies have shown that the levels of histone methylation and the recruitment of histone methyltransferase with transcription factors are critical for their transcriptional activity Demers et al., 2007; McKinnell et al., 2008; Miller et al., 2008) . In agreement with this view, we have defined subtle classes of bivalent domains, each with distinct annotations, transcriptional responses, and binding variability within the endoderm. Group 1 represents the bivalent domain whose function is to regulate 'Developmental Genes' which recapitulates previous findings (Bernstein et al., 2006) . In addition, we showed another subclass bivalent group, Group 4, which is strongly annotated to neuronal activities (122/414 genes (29.5%), Bonferroni P = 1.08E-20) and cell communication (167/849 genes (19.7%), Bonferroni P = 3.27E-1). Group 4 is likely to represent the bivalent domains whose function is to fulfill cell signaling as previously discussed (Ku et al., 2008) . Since these various bivalent groups revealed in derived endoderm are associated with distinct annotations and display unique histone marks, they can be further classified into the types associated with Polycomb repressive complexes (PRC) (Ku et al., 2008) . Groups 1 and 4 are likely to be PRC1-positive because they exhibit large H3K27me3 regions and maintain the bivalent conformation during differentiation as well as are strongly annotated to development and cell signaling. Interestingly, Groups 5, 6 and 7 are likely to contain PRC1-negative bivalent domains which emerge during endoderm formation as they display narrow H3K27me3 regions and are associated with non-developmental functions such as protein and DNA metabolism.
While many inroads have been made in understanding endoderm formation in vertebrates, the next paradigm shifts in embryology will be advanced by the application of new technologies. As ChIP-seq becomes more utilized in the scientific community, many reports have described transcription factor binding in hESCs and other developmental cell types (Boyer et al., 2005; Cole et al., 2008; Fujiwara et al., 2009; Yu et al., 2009 ). To date, our datasets are unique, representing not just a single transcription factor, but a complex of factors. Furthermore, these datasets follow the dynamics of this complex of transcription factors through developmental time -from hESC pluripotency to the transformation of hESC into endoderm. An in depth analysis of the relationship between the datasets for SMAD2/3, SMAD3, SMAD4, FOXH1, H3K4me3 and H3K27me3 provides insight into mechanisms underlying how SMAD transcription factors mediate Nodal signaling to specify endoderm. One of the surprising findings from this study is that SMAD2/3, SMAD3 and SMAD4 binding is highly dynamic; few specific bound regions are maintained from hESCs to endoderm. This suggests that the SMAD transcription complex is constantly in flux, using a variety of different sites to elicit activation of individual loci. Furthermore, we also show that FOXH1 has very different binding behavior than the SMAD proteins. First, throughout differentiation, FOXH1 maintains association with the same general genomic locations, whereas SMAD proteins become far more localized in intergenic regions once cells have become endoderm. Second, upon differentiation FOXH1 exhibits widespread binding throughout the genome whereas the SMADs become far more restricted to specific locales. This is consistent with a role of FOXH1, not specifically as a transcriptional activator, but as a pioneer protein which associates with chromatin to recruit histone modifiers to these loci (Cirillo et al., 2002; Cirillo and Zaret, 1999) .
Nodal signaling is reused throughout development to guide the formation of a plethora of tissue types. It has also been implicated in several cancers (Gupta et al., 2004; Lee et al., 2010; Mangone et al., 2010; Xu et al., 2004) . Despite the importance of this signaling pathway, few direct targets have been elucidated since the SMAD transcription factors were identified more than 15 years ago. Here we provide a toolbox for the regions bound by the transcription factors SMAD2/3, SMAD3, SMAD4 and FOXH1 and the histone modifications H3K4me3 and H3K27me3 in both hESCs and derived endoderm that can be used for the functional examination of thousands of additional targets. These targets, several of which are bound by the SMAD complex in both hESCs and derived endoderm, may also be bound and activated in a multitude of other normal and diseased cell types. Thus, we anticipate that the analysis of these factors will have wide-spread benefit to the scientific community by providing both thousands of SMAD targets for further analysis and genomic data that can continually be mined.
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